← All trials
NCT04487574
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 25, 2020
- Primary completion
- Oct 29, 2020
- Completion date
- Oct 29, 2020
- First posted
- Jul 27, 2020
- Last posted
- Nov 13, 2020
- Enrollment
- 118
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Pharmenterprises LLCLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.